Jennifer Moïsi

Program Leader, Meningitis & Pneumonia

Photo of Jennifer Moïsi

Dr. Jennifer Moïsi oversees AMP’s meningitis and pneumonia activities. Her responsibilities include project development and design, epidemiological and clinical data analysis, and the development of expertise for meningitis and pneumonia vaccination strategies. Her areas of expertise include bacterial disease surveillance,
pneumonia and meningitis diagnostic methods,
pneumococcal vaccines, demographic surveillance (data management and analysis), and international public health.

Before joining AMP in 2011, Dr. Moïsi worked at the University of Oxford and KEMRI-Wellcome Trust Research Programme in Kenya as an epidemiologist. In this role, she advised the Kenya Ministry of Public Health and Sanitation Division of Vaccines and Immunization on the establishment of a National Immunization Technical Advisory Group, developed and consolidated data quality control processes for a demographic surveillance study in Kilifi, Kenya, and analyzed demographic and hospital surveillance data to examine trends in child mortality and pneumococcal disease.

Dr. Moïsi has also worked at the Johns Hopkins Bloomberg School of Public Health with the PneumoADIP and the Center for American Indian Health. Most recently, she was principal investigator of the “Evaluation of the Binax NOW® S. pneumoniae immuno-chromatographic test and real-time lytA PCR for diagnosis of pneumococcal pneumonia and sepsis in low- and middle-income countries.”

Dr. Moïsi holds a PhD in international health and an MHS in biostatistics from the Johns Hopkins University as well as an engineering degree from the French Ecole polytechnique.